Glenmark Launches Tevimbra Lung Cancer Drug in India
June 24, 2025 19:32
Glenmark Pharmaceuticals launches Tevimbra, a new lung cancer treatment drug, in India. This marks Glenmark's entry into immuno-oncology, offering a significant advancement in cancer treatment.